Drug · DIN 02520192
LYUMJEV
BOX OF 5. 3 ML CARTRIDGES
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since September 14, 2021.
- Drug Identification Number (DIN)
- 02520192
- Company (DIN owner)
- Eli Lilly Canada IncToronto, Ontario, Canada
- Schedule
- Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous; Intravenous
- Therapeutic class (ATC)
- Insulin lispro A10AD04
- Class
- Human
- Record last updated
- August 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INSULIN LISPRO | 300 UNIT | 3 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 14, 2021: NOC 26649New Drug Submission (NDS)
Other DINs named LYUMJEV
- DIN 02520184 · Approved